Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126818781 | 12681878 | 1 | I | 20160811 | 20160824 | 20160824 | EXP | CA-MYLANLABS-2016M1033780 | MYLAN | 0.00 | Y | 0.00000 | 20160824 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126818781 | 12681878 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | U | 76418 | 5 | MG | TABLET | QD | ||||
| 126818781 | 12681878 | 2 | C | NORVASC | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 126818781 | 12681878 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | U | 0 | |||||||||||
| 126818781 | 12681878 | 4 | C | ACCUPRIL | QUINAPRIL HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126818781 | 12681878 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126818781 | 12681878 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126818781 | 12681878 | Blood pressure fluctuation | |
| 126818781 | 12681878 | Drug effect incomplete | |
| 126818781 | 12681878 | Headache | |
| 126818781 | 12681878 | Influenza like illness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |